CAS RN: 34367-04-9

Ginsenoside Ro

Product Availability

Choose a grade to view its available package options.

6 package records6 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260116 100mg In stock Shanghai Inquiry
Batchno.20251011 10mg In stock Shanghai Inquiry
Batchno.20260505 250mg In stock Shanghai Inquiry
Batchno.20250902 25mg In stock Shanghai Inquiry
Batchno.20250610 50mg In stock Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20251109 20mg In stock Shanghai, Shandong Inquiry
  • Product code: ICTG0586
  • Purity/Analytical Methods: >98.0%(HPLC)
GET A QUOTE

34367-04-9 / (2S,3S,4S,5R,6R)-6-[[(6aR,6bS,8aS,12aR,14bR)-4,4,6a,6b,11,11,14b-heptamethyl-8a-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3,4-dihydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylic acid

Standard CAS: 34367-04-9 Multi CAS: Yes

Basic Information

CAS
34367-04-9
Multi CAS
Yes
Molecular Formula
C48H76O19
Molecular Weight
957.100000
Exact Mass
956.498080
InChI
InChI=1S/C48H76O19/c1-43(2)14-16-48(42(61)67-40-35(58)31(54)29(52)24(20-50)63-40)17-15-46(6)21(22(48)18-43)8-9-26-45(5)12-11-27(44(3,4)25(45)10-13-47(26,46)7)64-41-37(33(56)32(55)36(65-41)38(59)60)66-39-34(57)30(53)28(51)23(19-49)62-39/h8,22-37,39-41,49-58H,9-20H2,1-7H3,(H,59,60)/t22-,23-,24-,25?,26?,27?,28-,29-,30+,31+,32+,33+,34-,35-,36+,37-,39+,40+,41-,45+,46-,47-,48+/m1/s1
InChIKey
NFZYDZXHKFHPGA-BPQKMSRTSA-N

Computed Properties

Structural Parameters

Heavy atom count
67
Fraction Csp3
0.92
Rotatable bonds
9
H-bond acceptors
18
H-bond donors
11
Molar refractivity
230.72
TPSA
312.05

LogP / Solubility

WLOGP
0.23
MLOGP
0.3
XLogP3
2.7
Consensus LogP
1.08
Log S (ESOL)
-5.33
Class (ESOL)
Slightly soluble
Log S (Ali)
-7.58
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-7.15
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-8.39

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
10

Get In Touch

Contact Us